MPS Pharmaa Limited (BOM:531686)
India · Delayed Price · Currency is INR 1.990
0.00 (0.00%)
At close: Aug 31, 2026
MPS Pharmaa Market Cap
MPS Pharmaa has a market cap or net worth of 38.03 million as of September 4, 2026. Its market cap has decreased by -7.01% in one year.
Market Cap
38.03M
Enterprise Value
113.26M
Revenue
356.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.99
ChartMarket Cap Chart
Since January 18, 2005, MPS Pharmaa's market cap has decreased from 108.87M to 38.03M, a decrease of -65.07%. That is a compound annual growth rate of -4.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 38.03M | 7.57% |
| Dec 29, 2025 | 35.36M | -56.06% |
| Dec 30, 2024 | 80.46M | 50.90% |
| Dec 26, 2023 | 53.32M | 46.07% |
| Dec 14, 2022 | 36.50M | 50.39% |
| Dec 27, 2021 | 24.27M | 243.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Norris Medicines | 136.51M |
| Unjha Formulations | 130.79M |
| Beryl Drugs | 124.71M |
| Ortin Global | 122.05M |
| Emmessar Biotech & Nutrition | 118.76M |
| Ganga Pharmaceuticals | 70.94M |
| Vivanza Biosciences | 70.00M |
| Brawn Biotech | 68.11M |